Leona Plum‐Mörschel
Profil Institute for Metabolic Research(DE)
Publications by Year
Research Areas
Diabetes Treatment and Management, Diabetes Management and Research, Pancreatic function and diabetes, Metabolism, Diabetes, and Cancer, Hyperglycemia and glycemic control in critically ill and hospitalized patients
Most-Cited Works
- → MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study(2018)295 cited
- → Effect of the sodium glucose co‐transporter 2 inhibitor canagliflozin on plasma volume in patients with type 2 diabetes mellitus(2014)240 cited
- → Randomised clinical trial: semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non‐alcoholic fatty liver disease assessed by magnetic resonance imaging(2021)200 cited
- → Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial(2019)170 cited
- → Efficacy, Safety, and Mechanistic Insights of Cotadutide, a Dual Receptor Glucagon-Like Peptide-1 and Glucagon Agonist(2019)116 cited
- → Euglycaemic glucose clamp: what it can and cannot do, and how to do it(2016)111 cited
- → Pharmacodynamic differences between canagliflozin and dapagliflozin: results of a randomized, double‐blind, crossover study(2014)91 cited
- → Validation of a Novel Method for Determining the Renal Threshold for Glucose Excretion in Untreated and Canagliflozin-treated Subjects With Type 2 Diabetes Mellitus(2013)87 cited
- → Oral Insulin Reloaded(2014)71 cited
- → Phase I studies of the safety, tolerability, pharmacokinetics and pharmacodynamics of the dual glucagon receptor/glucagon‐like peptide‐1 receptor agonist BI 456906(2022)56 cited